Insider · CIK 0001829614
Maria Arantxa Horga
Files at AVIR (Atea Pharmaceuticals, Inc.). First filing -, latest -.
Maria Arantxa Horga files SEC Form 4 as officer at AVIR (Atea Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Maria Arantxa Horga has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Common Stock | +51,283 | - | - | 112,159 | Feb 3, 2026 |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | FTax withholding Common Stock | -16,073 | $4.24 | $68k | 96,086 | Feb 3, 2026 |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -41,533 | $0.00 | $0 | 0 | Feb 3, 2026 |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -9,750 | $0.00 | $0 | 0 | Feb 3, 2026 |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +173,500 | $0.00 | $0 | 173,500 | Feb 3, 2026 |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Common Stock | +41,533 | - | - | 67,197 | Feb 4, 2025 |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | AGrant or award Common Stock | +9,750 | - | - | 76,947 | Feb 4, 2025 |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | FTax withholding Common Stock | -16,071 | $3.06 | $49k | 60,876 | Feb 4, 2025 |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -41,533 | $0.00 | $0 | 41,533 | Feb 4, 2025 |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +9,750 | $0.00 | $0 | 9,750 | Feb 4, 2025 |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +192,800 | $0.00 | $0 | 192,800 | Feb 4, 2025 |
Questions about Maria Arantxa Horga
Answered from the filings on this page, as of the latest one.
Is Maria Arantxa Horga buying or selling?
Maria Arantxa Horga has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Maria Arantxa Horga's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Maria Arantxa Horga has 0.
Where does Maria Arantxa Horga file Form 4?
Maria Arantxa Horga has filed Form 4 at AVIR (Atea Pharmaceuticals, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.